Sandra Kane-Gill


Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP, is a Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. Additionally, she is the current Interim Chair of the Department of Pharmacy and Therapeutics. She has secondary appointments in the School of Medicine in the Clinical Translational Science Institute, Department of Critical Care Medicine and the Department of Biomedical Informatics. She also serves as Professor for the Center for Critical Care Nephrology. In addition to her academic appointments, Dr. Kane-Gill is a Critical Care Medication Safety Pharmacist at the University of Pittsburgh Medical Center in the Department of Pharmacy.

Dr. Kane-Gill received her Bachelor of Science degree in pharmacy from Wayne State University in Detroit, Michigan. She completed a pharmacy practice residency accredited by the American Society of Health-System Pharmacists at West Virginia University Hospital in Morgantown, West Virginia, and earned a Doctorate of Pharmacy degree from the University of Toledo in Toledo, Ohio. Dr. Kane-Gill then pursued her Master of Science degree in Pharmacy Administration with an emphasis on Pharmacoeconomics and Health Outcomes at The Ohio State University in Columbus, Ohio and she completed a critical care fellowship at The Ohio State University. Recently, Dr. Kane-Gill completed a certification program in implementation science through the CTSI online training program at the University of California, San Francisco.

Dr. Kane-Gill’s interests focus on the assessment of clinical, economic and quality outcomes for critically ill patients. Her goal is to build a pharmacovigilance program to identify effective approaches for the detection, prevention, and management of medication errors and adverse drug events as to improve quality of care and patient safety. She led several pharmacoepidemiology evaluations that improved patient safety surveillance systems, prevented medication errors and adverse drug events (ADEs) and used health information technology (clinical decision support systems, telemedicine, simulation) to improve services. She applies implementation science strategies to ensure the adoption of evidence-based medication safety practices. Dr. Kane-Gill is a federally funded researcher serving as Principal Investigator (AHRQ, NIDDK) and Co-Investigator (AHRQ, NCCIH, NLM, Jewish Healthcare Foundation) on several research grants in this area of study.

Her work has been presented at several professional meetings with over 180 invited presentations and 200 abstract presentations. She has published 250 articles and book chapters related to critical care and patient safety. Her endeavors include editing published books on the use of high-risk intravenous medications in special patient populations and drug-induced complications in critically ill patients. She is on the editorial board for Critical Care Medicine and Annals of Pharmacotherapy. Dr. Kane-Gill is an active member of the American College of Clinical Pharmacy (ACCP), and Society of Critical Care Medicine (SCCM). She is a faculty member of the Research and Scholarship Academy of ACCP. In 2022, she held the elected position of President of the Executive Committee for the Society of Critical Care Medicine (SCCM), which is the decision-making body regarding the governance of SCCM. She is a fellow in the American College of Critical Care Medicine and the American College of Clinical Pharmacy.

Graduate Program Affiliation(s)
Pharmaceutical outcomes and policy research,MS in PharmacoAnalytics - Pharmaceutical Outcomes Research
Fellowship Program Affiliation(s)
PharmacoAnalytics and Implementation Science
Practice Area/Expertise
Medication Safety
Honors / Awards
Recent Awards:
2023 American College of Clinical Pharmacists (ACCP) Therapeutic Frontiers Lecture Award- honors an outstanding, internationally recognized scientist whose research is actively advancing the frontiers of pharmacotherapy.
2023 American Associate of Colleges of Pharmacy (AACP) Paul R. Dawson Award for Excellence in Patient Care Research –
2023 Expertscape: Expert in Acute Kidney Injury
2021 ASHP Literature Award for Sustained Contributions. ASHP Foundation
2021 Pharmacy Residency Excellence Awards
2021 Expertscape: Expert in Medication Errors- top 1% of scholars in the world writing about Medication Errors over the past 10 years and acknowledge on World Patient Safety Day
2020 UPMC Quality and Safety Fair- Safety award (second place)
2019 Pennsylvania Pharmacists Association Excellence in Innovation Award recognizes a pharmacist who is involved in an innovative pharmacy practice resulting in improved patient
2019 West Virginia University Hospitals, Commitment to Pharmacy Excellence Award
2016 ASHP Residency Excellence Award- Preceptor
2016 ASHP Award for Innovation in Pharmacy Practice for outstanding contribution to the biomedical literature
Recent Publications

Complete publication list found at:….

Selections from a list of 200 peer-reviewed publications:

Recent Presentations:

November 2022
1. Acute Kidney Injury Diagnosis and Management
Multiprofessional Critical Care Review Course (MCCRC)
2. The Future of Antimicrobial Use in the ICU: Considerations in Sepsis Management
3. Strategies for Improving Critical Care: Does the ICU really need a specialized pharmacist?
10th International Conference of the Egyptian Society of Intensive Care and Trauma (ESCIT), Cairo, Egypt

November 2022 Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI - KDIGO Conversations in Nephrology Podcast (Episode 9)

November 2022 Nephrotoxin Stewardship - Plenary
West-China Mayo International Forum of Critical Care Medicine, Chengdu City, Sichuan Province, P.R. China

November 10th, 2022
1. Pharmacy Services: Indicators for Results- How do I do it?
2. Pain: Patient Experience and Satisfaction: How to measure it?
3. Artificial Intelligence in Intensive Care
27th CBMI Brazilian Congress of Intensive Care Medicine, Brasilia, Brazil

November 2022
1. The Future of Critical Care Medicine
2. The Future of Antimicrobial Use in the ICU
Chinese Society of Critical Care Medicine (CSCCM), Tianjin, China (virtual >100,000 participants)

November 2022
1. ICU-Liberation: Implementation strategies for the A-F bundle
2. Implementation Science: Considerations for the Critically Ill
XIV Iberian Pan American Congress, Lima, Peru

October 2022 Global Guidelines: from research to bedside practice
European Society of Intensive Care Medicine 35thth Annual Congress, Paris, France

October 2022 Overcoming Barriers to Guideline Implementation in the ICU- Plenary; Colegio Mexicano de Medicina Critical (COMMEC), Guadalajara, Mexico

October 4, 2022
1. The Future of Critical Care Medicine
2. The Future of Antimicrobial Use in the ICU
3. Perioperative Use of Novel Biomarkers for Acute Kidney Injury
2nd Annual International Anesthesia and Acute Care Conference, Abu Dhabi, UAE

August 2022 Promoting Best Practices in the ICU with Safe Medication Use Guidelines
Southeast Chapter of Society of Critical Care Medicine (Virtual)

August 2022
1. Critical Care Nephrology symposium talk: Nephrotoxin stewardship
2. Global health care of critically ill patients - symposium talk: Intensive Care Unit Quality Improvement
3. ICU of the Future symposium talk: The future of antimicrobial use in ICU using advanced technology and data science
Asian Pacific Intensive Care Symposium (APICS), Singapore

June 2022 Implementation Science: Changing Practice in Critical Care; Carolinas-Virginias Chapter SCCM Symposium, Roanoke, VA

May 2022 Developing a Nephrotoxin Stewardship Program
42nd Korean Society of Critical Care Medicine Annual Congress- Acute and Critical Care Conference (ACCC), Kyungju, Korea 2022 (hybrid)

April 2022 Drug Induced Kidney Injury in the ICU: Mechanisms, Susceptibility, Diagnosis and Management Strategies
Virtual Journal Club Egyptian College of Critical Care Physicians, Cairo, Egypt